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Abstract
Background: We have used optic nerve injury as a model to study early signaling events in
neuronal tissue following axonal injury. Optic nerve injury results in the selective death of retinal
ganglion cells (RGCs). The time course of cell death takes place over a period of days with the
earliest detection of RGC death at about 48 hr post injury. We hypothesized that in the period
immediately following axonal injury, there are changes in the soma that signal surrounding glia and
neurons and that start programmed cell death. In the current study, we investigated early changes
in cellular signaling and gene expression that occur within the first 6 hrs post optic nerve injury.
Results: We found evidence of cell to cell signaling within 30 min of axonal injury. We detected
differences in phosphoproteins and gene expression within the 6 hrs time period. Activation of
TNFα and glutamate receptors, two pathways that can initiate cell death, begins in RGCs within 6
hrs following axonal injury. Differential gene expression at 6 hrs post injury included genes involved
in cytokine, neurotrophic factor signaling (Socs3) and apoptosis (Bax).
Conclusion: We interpret our studies to indicate that both neurons and glia in the retina have
been signaled within 30 min after optic nerve injury. The signals are probably initiated by the RGC
soma. In addition, signals activating cellular death pathways occur within 6 hrs of injury, which likely
lead to RGC degeneration.
Introduction
Axonal damage of long projecting neurons leads to retro-
grade degeneration and loss of the soma of the neuron by
programmed cell death over a period of several days.
However, little is known about the timing of events in the
soma of the neuron immediately following damage to the
axon and how soon the affected neuron with axonal dam-
age signals surrounding glia and other neurons of the cat-
astrophic event.
Retinal ganglion cells (RGCs) are long projecting neurons
whose axons make up the optic nerve. To determine the
temporal sequence of cellular signals and interactions fol-
lowing axonal injury, we have used optic nerve crush. The
somas of the RGCs are in a single layer in the retina and
are easily sampled and visualized. Similarly, the glia and
other retinal neurons that are associated with the RGCs
are also in specific layers and can be readily observed by
immunohistochemistry.
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Most studies of optic nerve damage leading to RGC loss
make observations of the changes in gene expression, the
level of a particular molecule or activation of a pathway
starting at 24–48 hrs following the injury [1-3]. For exam-
ple, inactivation of phospho-AKT and phospho-BAD have
been reported as early as 48 hrs after injury [1]. Upregula-
tion of proapoptotic proteins such as BAX and BIM has
been reported at 24 hr post injury [4-6]. Seven days after
optic nerve crush, there is increased caspase-3 activity and
significant loss of RGCs [6-8].
In the work presented here, we have looked for changes in
the retina within 6 hrs following optic nerve crush. Our
interest was not biased towards any one pathway that had
changed, but to use any changes that we found to deter-
mine the timing of cellular events and cell to cell signal-
ing, particularly those that may precede degeneration.
Thus, the work presented here attempts to answer the fol-
lowing questions:
1. When does the soma of the RGC "sense" that its axon
has been injured?
2. Which cells in the retina are signaled by the RGCs that
a catastrophic event has occurred?
3. Are cell death signals apparent in the first 6 hrs follow-
ing injury to the axon?
4. Are there nuclear events in the first 6 hrs following
injury to the axon?
We used phosphoproteomics and microarrays to find
early protein and gene expression changes following
axonal damage that could be followed up with immuno-
blots, immunohistochemistry and RT-PCR. We then used
our results to deduce a temporal sequence of cell to cell
interactions and representative signaling events in the ret-
ina following optic nerve injury. We interpret our results
to indicate that within 30 min of the axonal injury, the
RGC soma has detected the axonal damage and has
already signaled other cells throughout the retina. In addi-
tion, cell death pathways have been activated within 6 hrs
of the axonal injury and changes in gene expression have
been initiated by 6 hrs.
Results
Detection of phosphoproteins in the retina after optic 
nerve injury
We reasoned that phosphorylation of proteins would par-
ticipate in initial responses; therefore, a proteomics
approach was used to establish that there are phosphor-
ylation events within the first 6 hrs following axonal
injury. Database searching of the mass spectrometry data
was used to identify the captured phosphoproteins (Addi-
tional file 1) and to obtain a differential, temporal spec-
trum of phosphoproteins. The detected phosphoproteins
were further analyzed using Gene Ontology (GO) pro-
grams, GoMiner [9] and ProfCom [10] to identify "enrich-
ment" of phosphoproteins within the context of
categories of cellular pathways. Enrichment of phospho-
proteins refers to detection of changes beyond expected
from a random distribution. The "changed" p-values are
based upon Fisher's test for significance [9]. Table 1 con-
tains the GO categories of biological processes with
respect to phosphoproteins that were significantly (p <
0.05) enriched, compared to control tissue, after axonal
injury. Note that enrichment of phosphoproteins
occurred in intracellular signaling, protein kinase, modu-
lation of transcription and ion channel categories, among
others.
Table 2 presents a selected list of phosphoproteins that we
culled from the enriched GO categories. These results
demonstrate that within the first 6 hrs following axonal
injury, there were changes in the phosphorylation of pro-
teins associated with pathways involving intracellular sig-
nal transduction via MAPK-ERK-1, glutamate/Ca2+
signaling, TNFα activity and transcription factors. The
variety of the detected phosphoproteins indicated that sig-
naling pathways from the plasma membrane to the
nucleus become activated through phosphorylation
events. We further investigated these identified pathways
because of their relevance to initiation of cell death and/
or regulation of cell survival.
Elaboration of signaling pathways detected by 
phosphorylation screening after optic nerve injury
ERK-1 signaling
Although the phosphoproteomics method did not detect
phosphorylated ERK-1 (Map kinase 1), we detected the
phosphorylation of regulators of ERK-1 activation (Table
2). For example, OSBP (oxysterol binding protein) regu-
lates the activation of ERK-1 by way of binding to phos-
phatases that act on phosphorylated ERK-1 [11], MAGI-3
regulates activation of ERK-1 by lysophosphatidic acid
(LPA) [12] and USP8, also known as UBPY, is a deubiq-
uination enzyme that promotes degradation of the epider-
minal growth factor receptor [13], which is a known
activator of the ERK-1 pathway.
Therefore, we tested for the activation of ERK-1. By immu-
noblot, activated ERK-1 (pERK1) appeared to decrease at
30 and 60 min after optic nerve injury, but increased sig-
nificantly at 6 hrs (Figure 1A–B). Immunohistochemistry
showed activated ERK-1 primarily in the Muller cells of
control retinas (Figure 1C). However, after optic nerve
injury, the distribution of pERK-1 changed dramatically.
At 30 min, pERK-1 was no longer detected in Muller cells
but now appeared in the OPL and the inner layer of the
IPL (Figure 1D). Immunolabeling for pERK-1 in the OPL,
which contains photoreceptor synapses, was present at 30Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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min and persisted for at least 6 hrs after optic nerve crush
(Figure 1D–F). The increased labeling in the outer plexi-
form layer suggests that there were signals to the photore-
ceptors within 30 min following optic nerve crush. There
was also immunolabeling for pERK-1 in the inner stratum
of the inner plexiform layer at 30 min and 6 hrs and labe-
ling in the ganglion cell layer at 60 min. This dynamic, cel-
lular redistribution of activated ERK-1 following optic
nerve injury is striking and suggests that other cells in the
retina are rapidly responding to the axonal injury of the
RGCs.
Glutamate/calcium signaling
After optic nerve crush, we detected phosphorylation of
calmodulin (CALM1), the ionotropic glutamate receptor-
channel, GluR1 (GRIA), and other ion transport-related
proteins (Table 2). These results indicated altered calcium
signaling and increased activation of glutamate receptors.
Phosphorylation of the GluR1 occurs on tyrosine and ser-
ine residues [14]. Using lysates and membrane fractions
from whole retinas, we performed immunoblots with site
specific phosphoserine antibodies to GluR1. The Ser-831
and Ser-845 sites are adjacent to a putative tyrosine phos-
phorylation site (Tyr-812) in the carboxyl-terminal
domain of the receptor [14]. Increased phosphorylation
of Ser-831 was evident at 6 hrs (Figure 2A). Phosphoryla-
tion of Ser-845 was detected in the membrane pellet frac-
tion (Figure 2B) and was also increased at 6 hrs.
Immunohistochemistry was used to localize where in the
retina was phosphorylation of GluR1 occurring following
optic nerve crush. As shown in Figure 2C–F, there was
increased labeling of GluR1 in the ganglion cell layer by 6
hrs after axonal injury; whereas the labeling in the outer
plexiform layer remained relatively constant. The
increased phosphorylation of GluR1 by 6 hrs was consist-
ent using proteomics and immunohistochemistry.
TNF  signaling
In our phosphoprotein screen, several proteins related to
the TNFα pathway were detected following optic nerve
crush (Table 2). Therefore, we determined in the retina
the presence of the ligand and downstream protein
kinases that can be activated through the TNFα pathway.
As shown in Figure 3A, TNFα was detected in control ret-
inas but TNFα levels increased markedly by 6 hrs after
optic nerve injury.
If the TNFα pathway was activated, two major intracellu-
lar signaling pathways may also be activated: SAPK/JNK
and NFκB. The activation of SAPK/JNK over the 6 hrs time
course is shown in Figure 3B–C. Consistent with the
increased levels of TNFα by 6 hrs, there was a significant
increase in activated SAPK/JNK by 6 hrs after optic nerve
injury. By immunohistochemistry, pJNK was found
throughout the inner retina under control conditions and
at 30 and 60 min post optic nerve crush (Figure 3D, E and
Table 1: Gene Ontology Analysis of Phosphoproteins after Axonal Injury
GO ID Total Under Over Change p-Value Term
166 2142 7 20 27 0.0001 nucleotide binding
17076 1853 7 15 22 0.0014 purine nucleotide binding
30554 1533 6 13 19 0.0019 adenyl nucleotide binding
5524 1446 6 12 18 0.0024 ATP binding
7242 1200 5 8 13 0.0278 intracellular signaling cascade
16301 951 4 8 12 0.0118 kinase activity
5198 807 2 9 11 0.0092 structural molecule activity
16773 770 2 8 10 0.0175 phosphotransferase activity, OH acceptor
4672 669 2 7 9 0.0194 protein kinase activity
6468 673 2 6 8 0.0498 protein amino acid phosphorylation
30001 406 2 5 7 0.0113 metal ion transport
15672 321 1 5 6 0.013 monovalent inorganic cation transport
5216 353 1 5 6 0.0197 ion channel activity
15268 386 1 5 6 0.029 alpha-type channel activity
15267 407 1 5 6 0.0361 channel or pore class transporter activity
9966 443 2 4 6 0.0508 regulation of signal transduction
6813 168 1 4 5 0.0035 potassium ion transport
7017 216 3 2 5 0.0098 microtubule-based process
5261 254 1 4 5 0.0186 cation channel activity
3779 259 1 4 5 0.02 actin binding
5516 111 1 3 4 0.0045 calmodulin binding
5267 140 0 4 4 0.0101 potassium channel activity
3712 160 2 2 4 0.0158 transcription cofactor activity
5244 175 1 3 4 0.0212 voltage-gated ion channel activityCell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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3F). However, by 6 hrs after optic nerve injury (Figure
3G), increased activation of JNK was present within the
ganglion cell layer, which includes the RGCs. Thus, the
proteomics, immunoblots, ELISA and immunohisto-
chemistry all identify activation of the TNFα pathway,
most likely in the RGCs, by 6 hrs following optic nerve
injury.
We assayed for the activation of NFκB by means of a spe-
cific ELISA for phospho-Ser32 on the IκB subunit of
NFκB, immunoblot for phosphorylated protein and
phosphorylation of the p65 subunit of NFκB. None of
these assays demonstrated activation of the NFκB path-
way by 6 hrs following optic nerve crush (data not
shown). Other phosphoproteins related to TNFα signal-
ing (Table 2) may be responsible for the down-regulation
of NFκB (See Discussion).
Nuclear activity
Active transcription involves the dynamic, post-transla-
tional modification of histones and other proteins associ-
ated with chromatin, as well as transcription factors that
translocate to the nucleus depending upon their phos-
phorylation state. Table 2 contains several transcriptional
Table 2: Selected phosphoproteins identified in the neural retina after axonal injury*.
Accession Number Protein Direction** Description
Calcium/Potassium channels and regulators
IPI00407939 GRIA1 Up Glutamate receptor, ionotropic, AMPA1
IPI00467841 CALM1 Up Calmodulin 1
IPI00118978 HCN1 Up Hcn1 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
IPI00409286 TRPM4 Down Trpm4 Isoform 1 of Transient receptor potential cation channel subfamily M member 4
IPI00752412 ATP1A3 Down ATPase, Na+/K+ transporting, alpha 3 polypeptide
IPI00132450 RGS10 Up Regulator of G-protein signaling 10
IPI00122549 VDAC1 Up Isoform1 of VDAC Voltage-dependent anion-selective channel 1
Signal Transduction
TNF-alpha pathway
IPI00126078 JAK1 Up Tyrosine-protein kinase JAK1
IPI00122372 TTRAP Up TRAF and TNF receptor-associated protein
IPI00124590 CASP8AP2 Down Casp8ap2 CASP8-associated protein 2
IPI00348883 CARD9 Down Card9 Novel protein containing a caspase recruitment domain
IPI00108549 SDCCAG3 Down Sdccag3 serologically defined colon cancer antigen 3 isoform 1
IPI00124414 DAB2IP Down Dab2 interacting protein (ASK-interacting protein1)
MAPK-ERK-1 Pathway
IPI00755254 OSBP Up Similar to Oxysterol-binding protein 1
IPI00111234 MAGI3 Down Magi3 Membrane-associated guanylate kinase-related MAGI-3
IPI00171977 USP8 Up Ubiquitin carboxy-terminal hydrolase 8
IPI00170221 ARHGEF6 Up Rac/CDC42 exhange factor (GEF) 6
Nuclear Activity
IPI00753411 SYNE2 Up Similar to spectrin repeat containing, nuclear envelope 2 isoform a
IPI00460716 JMJD1A Up Isoform 1 of JmjC domain-containing histone demethylation protein 2A
IPI00461474 SYNE1 Up Synaptic nuclear envelope 1, full insert sequence
IPI00228557 TCF20 Up TCF20 (transcription factor 20) – SPBP
IPI00331063 XPO4 Up Exportin-4
IPI00751267 H2AO Up Similar to H2A histone family, member O
IPI00462466 SETD2 Up SET domain containing 2-Huntington interacting protein B (Histone methyltransferase)
IPI00761953 SFRS2IP Up Splicing factor, serine arginine rich 2 interacting protein
IPI00750315 DCP2 Up PREDICTED: similar to mRNA decapping enzyme 2
IPI00458583 HNRPU Up Heterogeneous nuclear ribonucleoprotein U
IPI00136883 PTBP1 Up hnRNP I Heterologous nuclear ribonuclear protein I
IPI00421190 STAG2 Up Stromal Antigen 2
IPI00119301 HES6 Up Transcription cofactor HES6
*Listing the proteins in Table 2 was based upon the following criteria: 1) the underlying peptides were detected at least twice in the data, 2) the 
identified protein has known phosphorylation sites in the Phosphosite database [50], and 3) the phosphoprotein levels changed (up/down) by 
approximately two-fold after axonal injury.
**Direction is the up or down change in phosphopeptide level based upon the average of the 30, 60 min and 6 hrs values divided by the control 
value.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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Activation of ERK-1 (MAPK1) Figure 1
Activation of ERK-1 (MAPK1). A. Western blots were probed with anti-ERK-1 (pThr202/pTyr204) antibody. There was 
constitutive activation prior to optic nerve crush. However, the phosphorylation ratio (pERK/ERK) increased further at 360 
min although the total ERK extracted was lower. B. Graph of the data in A normalized to the total ERK-1 protein. C-F Immu-
nohistochemistry of activated ERK-1, at 0, 30 min, 60 min, and 360 min (6 hr) after optic nerve crush, respectively. Increased 
labeling of cells in the OPL (down arrows) are particularly evident at 30 min as well as decreased labeling of Muller cells that 
extend the from the ONL to the GCL (arrowheads). Also note that there is immunolabeling for pERK-1 in the inner stratum 
of the inner plexiform layer at 30 min and 6 hrs (up arrows) and labeling in the ganglion cell layer at 60 min (arrowheads). The 
grayscale inset in C shows the staining of the Muller cell marker glutamine synthase. Red = pERK-1, Blue = DAPI.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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Phosphorylation of GluR1 Figure 2
Phosphorylation of GluR1. A. Phosphorylation of GluR1 at Ser-831 increased at 6 hrs after optic nerve crush. B. GluR1 
protein levels remained relatively constant, while phosphorylation of Ser-845 increased by 6 hrs. C-F. Immunohistochemistry 
of phosphorylated GluR1 (Ser-845) at 0, 0.5, 1, and 6 hrs after optic nerve crush. Increased pGluR1 is apparent in the ganglion 
cell layer (arrowheads) at 6 hrs after optic nerve injury. Red, = pGluR1, Blue = DAPI. IS, inner segment; ONL, outer nuclear 
layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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Activation of TNFα pathways Figure 3
Activation of TNF  pathways. A. Detection of TNFα by ELISA in the neural retina. Cytokine levels were determined in 
three samples at each time point. The level at 6 hr was significantly higher. B-C. Detection of phosphorylated JNK in the neural 
retina. B. Western blots (upper image) were probed with an anti pJNK antibody. C. ELISA confirmed the change in activation 
of JNK at 6 hrs after optic nerve injury. Data are normalized to total protein. D-G. Immunohistochemistry of activated JNK in 
the neural retina. Antibodies to pJNK were used on sections at 0, 30 min, 60 min and 6 hr after optic nerve crush. Increased 
labeling is evident in the GCL (arrows) at 6 hr.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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cofactors, such as TCP20, and HES6. TCP20 (also known
as SPBP- streomelysin-1 platelet-derive growth factor
responsive element binding protein) enhances the activity
of various transcription factors, including c-Jun [15].
HES6 is a basic helix-loop-helix transcription factor that
promotes neuronal differentiation [16] but inhibits astro-
genic differentiation [17]. HES6 is phosphorylated by
ERK-1 which is necessary for its anti-astrogenic activity
[17].
In our survey for nuclear phosphoproteins based on mass
spectrometry, we also found that H2A, JMJD1A (a histone
demethylase) and SETD2 (a histone methylase) were
phosphorylated within 6 hrs after optic nerve injury.
Using an antibody to phosphorylated H2A (pSer139), we
confirmed the phosphorylation state of this histone in the
neural retina following optic nerve injury. Western blot-
ting indicated that H2A is phosphorylated and that the
level of phosphorylation increased during the 6 hrs after
optic nerve injury (Figure 4A). The phosphorylation of
H2A may be related to chromatin remodeling [18,19] and
is also a feature of the initiation of apoptosis [20,21].
Because we detected phosphorylation of two proteins
involved in histone methlation/demethylation (JMJD1A
and SETD2 in Table 2), we further investigated selected
histone H3 methylation sites. To detect changes in histone
methylation, we used an antibody directed towards his-
tone H3 di and tri-methylated at K4. Trimethylation at
this site is associated with the active transcription of a
number of genes [22]. As shown in Figure 4B, H3-K4 tri-
methylation is constitutive, but decreases abruptly by 30
min, and recovers slightly at 6 hrs after optic nerve crush.
H3-K4 dimethylation also decreased with time after injury
(data not shown). Thus, the increase in H2A phosphoryla-
tion and changes in histone H3 methylation may be
linked to decreased transcription of certain genes within 6
hrs following optic nerve crush.
Differential gene expression in the ganglion cell layer post 
retinal injury
To examine the early changes in gene expression within
the ganglion cell layer after optic nerve crush, we per-
formed laser capture microdissection on retinal tissue sec-
tions to extract material from the ganglion cell layer. This
layer contains RGCs as well as astrocytes, displaced ama-
crine cells, microglia, vascular endothelia and the proc-
esses from Muller cells. Thus, laser capture microscopy
enriched our sample for RGCs compared to having used
full thickness retina. mRNA was prepared from ganglion
cell layer samples obtained from retina sections of eyes
with optic nerve crush and compared to ganglion cell
layer samples from control retina sections. Samples were
subjected to linear amplification and processing, followed
by hybridization to a mouse microarray (Affymetrix
Mu430 V2). A list of 220 differentially expressed genes
was obtained after filtering for a minimum 1.2- fold
change and p < 0.05 (Additional file 2). Changes in
selected genes were verified using qRT-PCR. We used gene
ontology analysis (GoMiner and ProfCom) to analyze
changes in gene expression with regard to cellular signal-
ing.
In the gene ontology analysis, expression of genes
involved in transcription and transcriptional regulation
were one of the most significant with 31 differentially
expressed genes (p = 0.01, Additional file 3). The increase
in nuclear gene phosphorylation that we found with
phosphoproteomics apparently leads to alterations in
transcriptional activity. Another category containing sig-
nificantly altered gene expression was phosphorylation
with 16 differentially expressed genes (p = 0.0035, Addi-
tional file 3). Table 3 contains a curated list of genes we
found in these GO categories grouped with respect to
functions in signal transduction, Ca2+ homeostasis and
cell death.
Histone phosphorylation and methylation Figure 4
Histone phosphorylation and methylation. Western 
blots probed with A. antiphospho-H2A (Ser-139) and B. tri-
methyl-K4 H3 histone. Phosphorylation of H2A increased 
while methylation of histone H3 (at lysine-4) decreased after 
optic nerve injury. The demethylation of H3 persisted for 
several hours and started to recover at 6 hr post injury. 
Actin served as a loading control in these experiments.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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We also found that expression of genes related to
cytokine/growth factor signaling was altered at 6 hrs post
injury. Socs3 and Atf2 were upregulated and Map3K10
was downregulated (Table 3). Atf2 is a transcription acti-
vator downstream of JNK, while Map3K10 is an activating
kinase upstream of JNK. Consistent with the microarray
results, qRT-PCR data confirmed the upregulation of
Socs3 (4.4-fold). Several differentially expressed genes at
6 hrs post injury were associated with regulation of cell
death pathways: Aifm3 and Bax are directly associated
with mitochrondria permeability channels that, when
opened, leads to apoptosis. We confirmed the upregula-
tion of Bax expression (1.6-fold) using qRT-PCR.
Using immunohistochemistry, we investigated which cell
types are differentially expressing SOCS3 and BAX pro-
teins at 6 hrs after optic nerve injury. As seen in Fig. 5A–B,
SOCS3 appears to be present throughout the retina but is
increased at 6 hrs, particularly in the Muller cells. Simi-
larly, BAX increased at 6 hrs, particularly in the ganglion
cell layer (Fig. 5C–D). Thus, the immunohistochemistry
demonstrating proteins was consistent with the mRNA
expression data. Expression of other cell death genes was
also apparent at 6 hrs (Table 3). Consistent with the lack
of activation of the NFkB pathway, we did not observe
upregulation of the anti-apoptotic factor Bcl-2 or caspase
inhibitors [23]. Thus, changes associated with the initia-
tion of programmed cell death may already have started in
RGCs within 6 hrs after optic nerve injury.
Discussion
We used a multidisciplinary approach to investigate the
temporal, intercellular and intracellular signaling that
immediately follow optic nerve injury. Our hypothesis
was that there are cellular events in different cells in the
retina very early after optic nerve injury. Our intent was
not to investigate all pathways or any one pathway in-
depth, but to find multiple signaling pathways, that
would be representative of sequential changes. Our data
provide a temporal, sequential framework of early events
within the first 6 hrs after optic nerve injury. Previous
studies have investigated changes in selected protein
phosphorylation [1] or gene expression [2,3] at one day to
several weeks after optic nerve injury. Thus, our data pro-
Table 3: Differential expression of selected genes in the ganglion cell layer 6 hrs after optic nerve injury
Genbank Fold
Group Gene Symbol Description Accession Change p-value
Signal transduction
Socs3 Suppressor of cytokine signaling 3 BB241535 3.33 0.0018
Gsk3b Glycogen synthase kinase 3 beta BG063622 1.39 0.0454
Akap9 A kinase (PRKA) anchor protein 9 BB109183 1.59 0.0165
Pdgfra Platelet derived growth factor receptor -alpha AW537708 1.50 0.0325
IL20rb Interleukin 20 receptor beta BE852308 1.84 0.0371
Prkcbp1 Protein Kinase C binding protein 1 AK014397 1.36 0.0417
Mast2 Microtubule associated serine/threonine kinase 2 NM_008641 1.30 0.0319
Map3k10 Mitogen activated protein kinase kinase kinase 10 AI851771 -1.48 0.0363
Calcium tansport/homeostasis
Camk2a Calcium/calmodulin-dependent protein kinase II alpha AW490258 1.32 0.0245
Cacng2 Calcium channel, voltage-dependent, gamma subunit 2 BB342913 1.26 0.0298
Itpr2 Inositol 1,4,5-triphosphate receptor 5 BC013815 -1.44 0.0102
Trpc2 Transient receptor potential cation channel, subfamily C, 
member 2
BC003841 1.24 0.0318
Gcm2 Glial cells missing homolog 2 AF081556 1.37 0.0224
Cell Death
Bax Bcl2-associated × protein BC018228 1.32 0.0275
Faim3 Fas apoptotic inhibitory molecule 3 AK007714 -2.48 0.0118
Atf2 Activating transcription factor 2 BM119623 1.25 0.0489
Ercc1 Excision repair cross-complementing rodent repair 
deficiency1
AW538163 -1.27 0.0155
Foxp1 Forkhead box P1 BM220880 1.27 0.0285
Nfatc4 Nuclear factor of activated T-cells, calcineurin-dependent 4 AV166177 -1.65 0.0387
Rasa1 RAS p21 protein activator AA124924 1.23 0.0390
Rtn4 Reticulon 4 BE988775 1.31 0.0187
Ski v-Ski sarcoma viral oncogene homolog AV381512 1.33 0.0371
Smad5 SMAD, mothers against DPP homolog 5 U77638 -1.7 0.0250
Aifm3 Apoptosis inducing factor, mitochondrion-associated 3 BF320633 1.31 0.0221Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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vides the first observation of responses in the neural retina
as early as 30 min after axonal injury.
As answers to the questions that were raised in the Intro-
duction of this paper, we believe that:
1. The soma of the RGC "senses" that its axon has been
injured within 30 min. This interpretation of our data is
based on the dramatic de-activation of the phosphoryla-
tion state of ERK1 in the Muller cells within 30 min.
Muller cells and astrocytes express activated ERK-1 in the
retina, and these cells express higher levels in retinas from
glaucomatous donors [24]. Muller cells wrap around the
somas of RGCs and have many points of contact. We
hypothesize that within 30 min, the somas of the RGCs
signal the Muller cells, which lead to loss of the activation/
phosphorylation state of ERK1 in the Muller cells. If there
are changes in Muller cell activity by 30 min post axonal
injury, the likely source of the signals to affect these
changes is the somas of the RGCs with damaged axons.
Thus, the somas of the RGCs have presumably "sensed"
that a cellular event has occurred.
2. The somas of the RGCs probably signal that a cata-
strophic event has occurred to many neurons and glia in
the retina within 30 min. Surprisingly, 30 min after acute
injury, when Muller cells have lost ERK-1 activation/phos-
phorylation, ERK-1 activation/phosphorylation simulta-
neously appears in the outer plexiform layer, the location
of the photoreceptor synapses, in the inner nuclear layer
and in the inner plexiform layer.
3. Cell death signals are apparent within 6 hrs following
injury to the RGC axon. These death signals include: an
Immunohistochemistry of differentially expressed proteins Figure 5
Immunohistochemistry of differentially expressed proteins. A-B: Expression of SOCS3 and C-D: BAX in the control 
and 6 hrs after optic nerve crush. SOCS3 was expressed throughout the retina and appeared increased in Muller cells (arrow-
heads) after optic nerve injury. Increased BAX labeling after optic nerve injury was particularly evident in the ganglion cell layer 
(arrows), consistent with pending programmed cell death of RGCs. Red = target antibody, Blue = DAPI.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
Page 11 of 16
(page number not for citation purposes)
increase in TNFα production and changes in phosphor-
ylation of related TNFα pathway proteins (CASP8AP2
(Flash), TTRAP, SDCCAG3, JNK, CARD9, and DAP2IP).
DABIP2 (AIP1) [25,26] is directly involved in signaling
from the TNFα receptors to activate JNK, while SDCCAG3
is involved in receptor trafficking [27]. These signals may
not be sufficient to induce cell death at 6 hrs but may be
part of the early events that lead to programmed cell
death. The lack of activation of the NFκB survival pathway
is consistent with changes in the phosphorylation of other
TNFα pathway components, (eg TTRAP, CARD9,
CASP8AP2) that can negatively regulate NFκB activation
[28-30]. Finally, protein kinase MAST2, which is upregu-
lated 6 hrs post optic nerve crush (Table 3), interacts with
TRAF6 in the TNFα pathway so as to decrease activation of
NFκB [31].
4. There are nuclear events causing new protein synthesis
within 6 hrs following injury to the RGC axon. Two new
proteins, for example, BAX and AIFM3, are associated
with the initation of programmed cell death; whereas,
another, RTN4, sequesters the antiapoptotic BCL-2 pro-
tein [32]. The decrease in histone methylation (Figure 5)
and the upregulation of transcription factors (Table 3) at
6 hrs after optic nerve crush are consistent with changes in
transcriptional activity. Furthermore, phosphorylation of
H2A at Ser-139 is associated with release of H2A from the
nucleus and apoptosis [18].
The increase in expression of Socs3 can be related to JAK1
activation [33] and cytokine induced degeneration. For
example, Socs3 is also upregulated in the neural retina
upon light-induced injury [34]. In these studies, the activ-
ity of one or more of the IL-6 family of cytokines (IL-6,
CNTF, NP, LIF, CLC) was the stimulus for Socs3 upregula-
tion. We did not detect upregulation of any single mem-
ber of the IL-6 family in our microarray data. Thus, as with
light-induced injury, multiple cytokines likely lead to the
increase of Socs3 expression.
The increased expression of Bax and other genes associ-
ated with programmed cell death is consistent with the
beginnings of a pro-apoptotic program that eventually
translocates BAX [5,6] and the related proapoptotic pro-
tein BIM [4,35] to the mitochondria to induce death in
RGCs. Upregulation of BAX protein has been shown to
persist after optic nerve crush [1,6]. Although a detailed
promoter analysis has not been reported, BAX upregula-
tion has been linked to JNK activation [36] that we
observed within 6 hrs of optic nerve injury. Bax knockout
mice are more resistant to RGC cell death after optic nerve
crush, but not to degeneration induced by glutamate exci-
totoxicity [37]. RGC cells in Bim knockout mice are also
protected from optic nerve axotomy-induced death [4].
The proapoptotic activity of Bim is negatively regulated by
ERK-1 phosphorylation, while phosphorylation by JNK
enhances Bim activity possibly by dissociation from intra-
cellular sequestration [38]. Phosphorylation of BIM by
ERK-1 causes its degradation by the proteosome [39] so
that the regional differences we observe in ERK-1 and JNK
activation (Figs 3 and 4) could affect Bim levels in various
cell types.
In addition, we note that there is limited survival signaling
in the retina immediately after optic nerve injury. Previ-
ous studies have shown that survival signaling by IGF-1
through the phosphoinositide-Akt pathway begins to
decrease within two days after optic nerve crush [1]. The
loss of IGF-1 signaling may be due to the upregulation of
Socs3 (Table 3) which is known to antagonize this path-
way [40] and interacts directly with the IGF-1 receptor
[41]. The changes in glutamate receptor phosphorylation
that we observed after optic nerve crush suggests that
altered Ca2+ signaling is part of the degenerative process.
Brain-derived neurotrophic factor (BDNF) is an impor-
tant trophic factor for RGC cells and has been shown to be
neuroprotective in RGC injury paradigms (Reviewed in
[42]). However, the upregulation of Camk2 and related
Ca2+ signaling (Tables 2 and 3) antagonizes the trophic
activity of BDNF [43]. Thus, application of BDNF, IGF-1,
and related factors [44] may be of only short-term benefit
after optic nerve injury.
Based on our data we offer the following hypothesis: The
soma of the RGC "senses" that its axon is damaged within
30 min and signals the Muller cells, which, we believe, sig-
nal the entire retina that a catastrophic event has occurred.
Furthermore, within 6 hrs of damage to the optic nerve,
death signals are present in the retina that will ultimately
lead to RGC degeneration. The temporal rapidity with
which these events occur suggest that attempting to inter-
fere with programmed cell death at a later time may be
fruitless and, perhaps, not possible
Experimental Procedures
Animal model
Retinas were obtained from male C57BL/6J mice. All
experiments were performed in accordance with the U.S.
Public Health Service Policy on Humane Care and Use of
Laboratory Animals, the National Institutes of Health
Guide for the Care and Use of Laboratory Animals, the
ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research, and institutional, federal, and state
guidelines regarding animal research. Groups of 5–9 mice
were subjected to optic nerve crush. Axons of the optic
nerve were crushed with fine forceps for 10 sec, 2 mm pos-
terior to the globe, under direct visualization, within an
intact meningeal sheath. By performing the optic nerve
crush 2 mm posterior to the globe, the injury is distal to
the entry of the ophthalmic artery into the optic nerve.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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Thus, care is taken to not disturb the retinal blood supply.
Optic nerve crush has been widely used by many labora-
tories and is well documented in the literature [45,46]. At
the desired times (30, 60 and 6 hrs after crush) eyes were
enucleated and neural retina removed and frozen at -
80°C. Controls (0 min) were contralateral eyes that had
not been injured from the same animals in each group.
Preparation of retinal extracts
Retinal tissue (55–100 mg) was homogenized in 150 μl of
lysis buffer (20 mM Tris-HCl, pH 7.4, containing 2 mM
EDTA, 150 mM NaCl, 1% (v/v) NP-40, multiple protease
inhibitor cocktail (Roche Applied Science, Indianapolis,
IN) and 1 mM sodium orthovanadate). A motorized pes-
tle was used in 3 × 20 sec bursts on ice. The mixture was
centrifuged at 15,800 × g for 20 min at 4°C. The superna-
tant was removed and the pellet re-extracted with 50 μl of
lysis buffer with mixing by up and down action of a
pipette. The mixture was centrifuged again and the super-
natants combined. Protein concentrations were measured
(BCA reagent, Pierce Chemical Co.).
Strategy
The initial screening for changes in phosphorylated pro-
teins was done using affinity capture methods coupled to
mass spectrometry for protein identification. These meth-
ods included anti-phosphotyrosine beads for enrichment
of tyrosine phosphorylated proteins followed by separa-
tion of the captured material using one-dimensional gel
electrophoresis. We used metal-ion chelate chromatogra-
phy of phosphopeptides obtained from proteins that were
not captured by anti-phospho-tyrosine antibodies. We
did these experiments at multiple points post injury to
attempt to capture a broad spectrum of events in cellular
signaling. Although the method used was only semi-
quantitative, it lends itself to detection of changes in mul-
tiple phosphoproteins for each experimental time point.
Isolation of phosphoproteins/peptides
Tyrosine-phosphorylated proteins were isolated by
immunocapture with anti-phosphotyrosine antibody
4G10 conjugated to agarose beads (Millipore Billerica,
MA). This antibody has been used previously to character-
ize tyrosine phosphoryated proteins in stimulated cell sys-
tems [47] and for quantitative phosphoprotein detection
[48]. Lysate containing 1 mg of protein was diluted 1:10
with lysis buffer without NP-40 detergent and applied to
50 μl of a slurry of 4G10-conjugate. The antibody binding
reaction was incubated at 4°C with gentle rocking for 16
to 24 hr. Beads were pelleted by centrifugation (2000
rpm, 3 min). The supernatant was removed and saved for
subsequent digestion and isolation of additional phos-
phopeptides (see below). The beads were washed two
times with 50 μl of lysis buffer without NP40 and the
washings combined with the original supernatant. The
beads were washed with lysis buffer (500 μl) without NP-
40 and the supernatants discarded. Proteins were eluted
from the beads by applying 50 μl of SDS-PAGE sample
buffer (Invitrogen) and heating to 95°C for 10 min. After
brief centrifugation, the supernatants were removed and
applied to individual lanes of a 4–12% polyacrylamide
gel (Biorad Criterion, Hercules, CA) and electrophoresed
at constant voltage. Gels were stained with Simply Blue
stain (Invitrogen, Carlsbad, CA) and de-stained in water.
In gel digestion of phosphotyrosine antibody-captured 
proteins
Each gel lane was cut into 10 bands (4 mm × 6 mm) and
further chopped into ~1 mm pieces and transferred to 1.5
ml Eppendorf tubes. Gel pieces were washed with 50 mM
ammonium bicarbonate, 50% acetonitrile solution (3 ×
15 min), and then in 100% acetonitrile. After removal of
the solvent and drying in a Speed Vac (Thermo-Fisher,
Pittsburgh, PA) concentrator, gels were rehydrated with
70–80 μl of 50 mM ammonium bicarbonate containing
0.01% (w/v) trypsin (Promega, Madison, WI). After incu-
bation at 37°C (16–24 hr), the reactions were stopped by
adding 1 volume of 5% (v/v) trifluoroacetic acid. The
supernatants were removed and gel pieces further
extracted twice with 100 μl of 0.1% trifluoroacetic acid/
60% acetonitrile for 30 min. Combined extracts were then
evaporated to dryness with a Speed Vac concentrator. The
residues were dissolved in 20 μl of 0.1% formic acid/10%
v/v acetonitrile).
Isolation of additional phosphopeptides from retinal extracts
The flow-through or non-bound fraction from the
antiphosphotyrosine capture step (above) was denatured
by addition of an equal volume of 6 M guanidine hydro-
chloride solution. Protein disulfides were reduced with
triscarboxyl-ethylphosphine (Sigma-Aldrich, St. Louis,
MO) (12.5 mM) at room temperature for 1 hr. To each
sample, iodoacetamide (in acetonitrile) was added to a
final concentration of 25 mM and the reactions incubated
in the dark for 1 hr. The solution was then transferred to a
dialysis cassette (10,000 MWCO) and dialyzed against 50
mM ammonium bicarbonate (1 L) at 4°C. The dialysis
buffer was changed 3–4 times over 24 hr. The retained
fraction was then concentrated in the Speed Vac to 0.5 ml
and then trypsin was added to a final concentration of
0.01% and incubated at 37°C for 20 hr. The reactions
were stopped by adding 10 μl of acetic acid. The reactions
were dried on a Speed Vac concentrator and re-dissolved
in 200 μl of 0.1% formic acid, 10% acetonitrile. The
OD280 of each solution was measured after 100-fold
dilution with water. A volume equivalent to 150 OD280
units of each sample was then diluted to 200 μl with 5%
acetic acid and applied to a Ga-conjugated phosphopep-
tide isolation cartridge (Pierce, Rockford, IL) that had
been rehydrated as per the manufacturer's instructions.Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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The flow-through from the cartridge was re-applied and
then washed with 200 μl of 0.1% acetic acid, 2 × 100 μl of
0.1% formic acid/10% acetonitrile. Peptides were eluted
with 2 × 75 μl applications of 0.1 M ammonia in 10%
methanol. One hundred μl of 5% acetic acid was then
added to the eluates and the samples evaporated to dry-
ness on the Speed Vac concentrator. The residue was re-
dissolved in 25 μl of 0.1% formic acid/10% acetonitrile.
Mass Spectrometry
Peptides from the gel bands of tyrosine phosphorylated
proteins were separated on a nano-flow column (0.075 ×
50 mm, C18 Agilent Santa Clara, CA). The column was
eluted at 0.3 μl/min with a gradient of 20 to 65% (v/v)
acetonitrile in 0.1% formic acid. Peptides from the phos-
phopeptide isolation cartridge were separated using auto-
mated two-dimensional chromatography on the Agilent
1100 chromatography system. In the first dimension,
phosphopeptides were injected onto a sulfated-ion
exchange column (PolyLC 0.3 mm × 50 mm (Columbia,
MD). Peptides were then eluted with steps of 0.05, 0.1, 0.2
and 0.4 M ammonium acetate onto a nanoflow column
(0.075 mm × 150 mm, Agilent). The column was eluted
at 0.3 μl/min with a gradient of 5–65% acetonitrile in
0.1% formic acid. Peptides were detected using an Agilent
1100 XCT ion-trap LC-MS system as described previously
[49]. Each sample from the gel band isolation was run
twice.
Data Analysis
Peptide mass and fragmentation data were filtered and
database searching done using Spectrum Mill software
(Agilent) as described previously [49]. We used the mouse
International Protein Index (IPI) database for searching
the mass spectrometry data generated from each sample.
From each sample run, a curated list of hits was obtained.
This list was based upon the database score and the qual-
ity of mass spectral data. For comparisons, we used only
those hits that were identified at least twice in each sam-
ple. The MS-data intensity values for each peptide were
then averaged over the three time points (3 0 min, 60 min,
6 hrs) and divided by averaged control values. The final
list of identified proteins is summarized in Additional file
1. This spreadsheet contains the sequences of phos-
phopeptides identified by mass spectrometry data. Also
included is the analysis for the presence of phosporylation
sites using Phosphosite [50].
Immunohistochemistry
Enucleated eyes were fixed in 2% wt/vol paraformalde-
hyde in 0.01 M phosphate buffered saline (PBS; pH 7.4)
at 4°C overnight. Six animals were used for each group in
all immunohistochemistry experiments. Immunohisto-
chemistry was performed on paraffin sagittal sections of
retina for pJNK (Cell signaling, Danvers, MA) using the
Vectastain Elite ABC kit (Vector Laboratories, Burlingame,
CA) and diaminobenzidine as a substrate. As a negative
control, sections were treated in the same manner, except
that incubation with primary antibody was omitted. The
sections were treated for equal time in DAB reagent and
photographed at the same time. Phosphorylated GluR1
(Ser-845, Zymed, Billerica, MA), phosphorylated ERK-1
(Cell Signaling) SOCS3 (Santa Cruz P-19, Santa Cruz,
CA), BAX (Santa Cruz H103), and glutamine synthase
(Chemicon-Millipore) were detected using Rhodamine-
labeled secondary antibody (Vector Labs). Nuclei were
stained with DAPI. Sections were washed, mounted and
viewed under a fluorescence microscope (Olympus,
AX70). As a negative control, sections were treated in the
same manner, except that incubation with primary anti-
body was omitted.
Isolation of retinal ganglion cell layer by laser capture 
microscopy (LCM)
The LCM system that we used (Veritas Microdissection
System, Molecular Devices, Sunnyvale, CA) obviated the
need for tissue dehydration prior to microdissection. This
enabled us to isolate quiescent retinal ganglion cells
directly from 8-μM frozen sections of mouse eyes, thereby
increasing the yield and quality of RNA (see below). Fro-
zen sections, mounted on special membrane-coated slides
(P.A.L.M. Microbeam), which facilitated the capture of
cells, were briefly (1 min) stained with hematoxylin (His-
toGene™; Arcturus, Mountain View, CA). In addition to
visualizing the retinal structures, this staining procedure
also removed the OCT mounting medium. Labeled sec-
tions were tracked with intergral light microscope using a
20× objective. Retinal ganglion cells to be isolated were
outlined with a "light" pen or cursor on a monitor screen.
Such an outline defined the area that would be cut and
catapulted intact into a Capsure Macro LCM cap (Molecu-
lar Devices, Sunnyvale, CA). In this manner, approxi-
mately 6000 cells from the ganglion cell layer were
isolated from each eye.
Total RNA Isolation and cRNA Amplification
Total cellular RNA from LCM-captured cells was isolated
and purified (Pico-Pure™; Arcturus). Samples of the total
starting RNA were analyzed by capillary electrophoresis
(Agilent Technologies, Palo Alto, CA) to assess the degree
of purification. Approximately 60 ng of total cellular RNA
could be extracted from 6000 cells from the ganglion cell
layer that were isolated by LCM. When this RNA was con-
trasted with commercially prepared total RNA from
mouse liver using picogram chips and a Bioanalyzer (Agi-
lent Technologies), sharp bands corresponding to the 18
S and 28 S RNA were observed for all samples RNA quality
was further assessed by calculating the RNA integrity
number, which is based on a proprietary Agilent Technol-
ogies algorithm. Total RNA from the isolated cells was
subjected to cRNA amplification. Briefly, 1.5 rounds of
cRNA amplification were accomplished using a Ribo-Cell Communication and Signaling 2009, 7:5 http://www.biosignaling.com/content/7/1/5
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Amp® OA RNA amplification protocol (Arcturus). First
strand cDNA was generated by reverse transcription using
the total RNA. After the second strand cDNA was synthe-
sized, a T7 RNA polymerase-driven cRNA synthesis was
performed to obtain the first round of cRNA amplifica-
tion. A second double strand cDNA synthesis was per-
formed followed by a second round of cRNA
amplification. A BioArray™  HighYield™ RNA transcript
labeling protocol (T7) (Enzo Life Sciences, Famingdale,
NY) was employed for the second round of amplification
to biotinylate the cRNAs. To examine the reaction quality,
an aliquot from the first stand cDNA synthesis in the first
round cRNA amplification and another from the second
strand cDNA synthesis in the second round amplification
sample were removed for real-time PCR analysis.
Microarray Analysis
Amplified RNA (8 μg) was hybridized to Affymetrix
(Santa Clara, CA) Mu430 v2.0 chips and processed as rec-
ommended by the manufacturer. Three chips each were
used for the control and 6 hrs crush samples. For each
dataset, invariant set normalization was performed using
the PM/MM model for calculating signal intensities in
dChip 2006 [51]. Thresholds for selecting significant
genes were set at a relative fold-difference of > 1.2, abso-
lute intensity difference between sample and baseline >
80, and paired t-test value of p <0.05. Genes meeting all
of these criteria were considered as significantly different.
This resulted in a list of 239 differentially expressed genes
(160 upregulated and 79 down regulated, Additional file
2). Microarray data have been deposited in the GEO data-
base with the series accession number GSE11862.
ELISA
ELISA assays for phosphoproteins were done with sand-
wich ELISA kits (Cell Signaling) following the manufac-
turer's instructions. These were used to detect
phosphoJNK (Thr183, Tyr185) and phospho IκB (Ser32)
in soluble tissue extracts. Briefly, extracts were diluted
with the assay buffer to the desired total protein concen-
tration (0.25, 0.5, 1.0 mg/ml) to 100 μl and applied in
duplicate to the wells of the ELISA plate containing the
capture antibody. Controls without added lysate were
included in all assays. The plates were covered and incu-
bated at 4°C for 12–16 hrs to allow binding of the target
protein to the plate. Wells were then washed 4 times with
the wash buffer supplied in the kit. The wells were then
covered and incubated with the antiphosphoprotein anti-
body and incubated for 1 hr at 37°C. The plates were
washed again and then incubated with horse radish per-
oxidase (HRP) linked detector antibody for 30 min at
37°C. The plate was washed again and then incubated
with HRP substrate solution for 30 min at room tempera-
ture. Stop solution was added and the absorbance of con-
verted substrate read at 450 nm in a plate reader.
Mouse TNFα was measured in soluble tissue extracts using
an ELISA kit (Pierce). Briefly, tissue extracts were diluted
to 0.25 or 0.5 mg/mL and 50 μl applied in duplicate to the
ELISA plate. TNFα standards over the range of 35 to1225
pg/ml were measured in duplicate along with the samples.
Then 50 μl of biotinylated antiTNFα antibody was added
to all of the wells and the plate covered and incubated for
2 hr at room temperature. The plate was washed 5 times
and then the wells were incubated with 100 μl of HRP-
streptavidin solution for 30 min at room temperature. The
reaction was stopped by adding an equal volume of acidic
(2N HCl) stop solution. The absorbance was then read at
450 nm in a plate reader.
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